Arcadia Biosciences (RKDA) Other Non-Current Liabilities (2014 - 2025)

Arcadia Biosciences has reported Other Non-Current Liabilities for 12 years, with the latest figure at $1.0 million in Q1 2025.

• For the quarter ending Q1 2025, Other Non-Current Liabilities fell 50.0% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2025 stood at $1.0 million (down 50.0% YoY), and the FY2024 full-year result was $2.0 million, changed 0.0% from the prior year.
• Other Non-Current Liabilities for Q1 2025 stood at $1.0 million, down from $2.0 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $2.1 million in Q1 2021, with the low at $1.0 million in Q1 2025.
• Historically, Other Non-Current Liabilities has averaged $2.0 million across 5 years, with a median of $2.0 million in 2022.
• Annual changes were most pronounced in 2021 — Other Non-Current Liabilities increased 7.0% — and 2025, when it sank 50.0%.
• Arcadia Biosciences' Other Non-Current Liabilities stood at $2.1 million in 2021, then fell by 3.38% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then slumped by 50.0% to $1.0 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $1.0 million (Q1 2025), $2.0 million (Q4 2024), and $2.0 million (Q3 2024), per Business Quant data.